论文部分内容阅读
BACKGROUND As the first-line regimens for the treatment of advanced gastric cancer, both docetaxel, cisplatin, and 5-fluorouracil (DCF) and epirubicin, cisplatin, and 5- fluorouracil (ECF) regimens are commonly used in clinical practice, but there is stil